AMREP, through its subsidiaries, is engaged in the real estate business. The company conducts its real estate business primarily in the City of Rio Rancho and certain adjoining areas of Sandoval County, NM. The company sells both developed and undeveloped lots to national, regional and local homebuilders, commercial and industrial property developers and others. The company also acquires land, focusing primarily in New Mexico, after completion of market research, soil tests, environmental studies and other engineering work, a review of zoning and other governmental requirements, discussions with homebuilders or other end-users of the property and financial analysis of the project and estimated development costs.

Bandwidth is a cloud-based communications platform-as-a-service (CPaaS) provider. The company's solutions include a range of software Application Programming Interfaces for voice and text functionality and its owned and managed, purpose-built Internet Protocol voice network. The company's operating segments include: CPaaS, which provides Voice, Messaging, 911 and Phone Numbers solutions through the company's proprietary CPaaS software application programming interfaces; and other, which consists of services provided such as SIP trunking, data resale, and a hosted Voice-over Internet Protocol and from traffic generated by other carriers, Short Message Service registration and other miscellaneous product lines.

Dril-Quip designs, manufactures, sells and services drilling and production equipment for use in deepwater, harsh environment and severe service applications. The company's products consist of subsea and surface wellheads, subsea and surface production trees, subsea control systems and manifolds, mudline hanger systems, connectors and associated pipe, drilling and production riser systems, liner hangers, wellhead connectors, diverters and safety valves. The company provides technical advisory assistance during installation of its products, as well as rework and reconditioning services. The company's customers may rent or purchase running tools from the company for use in the installation and retrieval of its products.

International Flavors & Fragrances is a creator and manufacturer of taste, scent and complementary adjacent products, including cosmetic active and natural health ingredients. The company's operating segments are Taste and Scent. The Taste segment develops a range of different flavors and taste offerings for its customers, most of which are tailor-made. The company's Taste business is comprised of various portfolios across flavor compounds, savory solutions, inclusions and nutrition and specialty ingredients. The Scent segment creates fragrance compounds and fragrance ingredients for the household and personal care products. The company also produces cosmetic active and functional ingredients for use in cosmetics.

Mersana Therapeutics is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates (ADCs) for cancer patients. The company's primary product candidate, XMT-1536, is an ADC targeting NaPi2b, an antigen broadly expressed in ovarian cancer and non small cell lung cancer. In addition, the company has established research and development partnerships with Merck KGaA and Asana Biosciences for the development and commercialization of additional ADC product candidates against a limited number of targets selected by the company's partners based on its Dolaflexin platform.

National Health Investors is a self-managed real estate investment trust, which focuses on sale-leaseback, joint-venture, mortgage and mezzanine financing of senior housing and medical facility investments. The company's portfolio consists of real estate investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, nursing facilities, hospitals and medical office buildings. The company's investments are structured as acquisitions of properties through purchase-leaseback transactions, acquisitions of properties from other real estate investors, loans or operations.

Phreesia is a provider of comprehensive solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform (the "Phreesia Platform"), the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and an integrated payments solution for secure processing of patient payments. The company's Platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients.

Reata Pharmaceuticals is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapies. The company focuses on on small-molecule therapeutics with mechanisms of action for the treatment of diseases with few or no approved therapies. The company's key programs are in rare forms of chronic kidney disease (CKD) and a rare neurological disease. The company's key product candidates include bardoxolone methyl (bardoxolone) in patients with CKD caused by Alport syndrome and omaveloxolone in patients with a neurological disorder called Friedreich's ataxia. The company is developing RTA 1701 for the potential treatment of a range of autoimmune, inflammatory, and fibrotic diseases.

Tela Bio is a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's products are an innovative solution that integrate multiple layers of minimally-processed biologic material with interwoven polymers in a unique embroidered pattern, which the company refers to as a reinforced tissue matrix. The company serves customers in the United States.